(Q28239014)

English

Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review

scientific article (publication date: 2004)

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review (English)

0 references

severe combined immunodeficiency

1 reference

based on heuristic

inferred from title

Mary Lou Lindegren

2

object named as

Mary Lou Lindegren

0 references

author name string

Lisa Kalman

1

0 references

Lisa Kobrynski

3

0 references

Robert Vogt

4

0 references

Harry Hannon

5

0 references

Joelyn Tonkin Howard

6

0 references

Rebecca Buckley

7

0 references

language of work or name

0 references

publication date

2004

1 reference

Genetics in Medicine

0 references

6

0 references

1

0 references

16-26

0 references

Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Primary cellular immunodeficiencies

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

A deletion in the gene encoding the CD45 antigen in a patient with SCID.

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Severe combined immunodeficiency with abnormalities in expression of the common leucocyte antigen, CD45

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Prenatal diagnosis and carrier detection for Athabascan severe combined immunodeficiency disease

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

T-cell immunodeficiencies

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Primary immunodeficiency diseases

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Oral and genital ulceration: a unique presentation of immunodeficiency in Athabascan-speaking American Indian children with severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Flow cytometric immunophenotyping in the diagnosis and follow-up of immunodeficient children

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Gene therapy. Seeking the cause of induced leukemias in X-SCID trial

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Gene therapy. Second child in French trial is found to have leukemia

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Chronic Progressive Poliomyelitis Secondary to Vaccination of an Immunodeficient Child

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Disseminated BCG infection in a patient with severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Omenn syndrome: a disorder of Rag1 and Rag2 genes.

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

The genetic and biochemical basis of Omenn syndrome

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Heterogeneity of phenotype in two siblings with adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Red cell adenosine deaminase (ADA) polymorphism in Southern Africa, with special reference to ADA deficiency among the !Kung

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Molecular basis for paradoxical carriers of adenosine deaminase (ADA) deficiency that show extremely low levels of ADA activity in peripheral blood cells without immunodeficiency

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Unexpected and variable phenotypes in a family with JAK3 deficiency

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Carrier and prenatal diagnosis of X-linked severe combined immunodeficiency: mutation detection methods and utilization

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Flow cytometric analysis of immunoprecipitates: high-throughput analysis of protein phosphorylation and protein-protein interactions

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Primary immunodeficiency disorders in Sweden: Cases among children, 1974?1979

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000105752.80592.A3

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28239014&oldid=2175147736"